Following a landmark gathering of over 2,200 life sciences supply chain leaders in April, LogiPharma’s 25th anniversary ...

(Reuters) -Pfizer and other drug companies have met with the Trump administration to discuss most-favored-nation pricing but ...

Selective estrogen receptor modulators are advancing notably in treating hormone‐driven conditions, offering opportunities across oncology and women' ...

A volatile stock market represents an ideal opportunity for long-term investors to pounce.

Green chemistry isn’t always top of mind for industrial drug discovery chemists. This 4-point plan can get it there ...

In the assessment of 12-month price targets, analysts unveil insights for BioNTech, presenting an average target of $138.7, a ...

We also implement any necessary process improvements or operational changes to prevent future issues.” The attorney general’s office launched its investigation after hearing testimony at ...

Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, ...

The Sport Impact Summit (SIS) has announced two major strategic partnerships with Scoreboard, sport’s leading AI-powered ...

Pivotal Phase 3 VERITAC-2 clinical trial results presented at ASCO demonstrate 2.9-month improvement in median progression-free survival when compared to fulvestrant in second line-plus patients with ...

Moderna will not be developing a vaccine to protect against bird flu — at least on the federal government’s dime. The U.S.

Pfizer (NYSE:PFE) recently ended its strategic collaboration with Acepodia and is facing legal challenges related to Depo-Provera, reflecting significant changes that provide a backdrop of strategic ...